Purdue Pharma agreed to pay 177.5 million in cash over five years plus addiction treatment medication worth 20 million to the Oklahoma State University Center for Health Sciences Center for Wellness and Recovery to settle a case brought by the state relating to Purdue Pharma's role in creating the opioid crisis in the state. The company also agreed to pay the state 60 million to cover its litigation costs and 12.5 million to help cities and counties in the state deal with the effect of the opioid crisis.